SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K:
[]
CNET [ChinaNet Online] 8-K: (Original Filing)
[Item 8.01. Other Events. On April 30, 2013, ChinaNet Online Holdings, Inc. (the "Company") received a letter from The NASDAQ Stock Market LLC ("NASDAQ") stating that for 30 consecutive business days immediately preceding the date of the letter the Company's common stock did not maintain a minimum closing bid price of $1.00 per share ("Minimum Bid Price Requirement") as required]
WUBA [58.com] EFFECT: .FormData {color: blue; background-color: white; font-size: small; font-family:
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
QUNR [Qunar Cayman Islands] FWP: (Original Filing)
[Issuer Free Writing Prospectus Registration No. 333-191459 October 30, 2013 Qunar Cayman Islands Limited Qunar Cayman Islands Limited, or our company, has filed a registration statement on Form F- 1, including a prospectus, with Commission, or the SEC, for the offering to which this free writing prospec tus relates. Before you invest, you should read the prospectus in that registration]
CO [Chinard Bloodrp] F-3/A: (Original Filing)
[Subject tompletion,ted October 30, 2013 PROSPECTUS $100,000,000 CHINARD BLOODRPORATION Ordinary Shares The securitiesvered by this prospectus may be offered and sold from time to time in one or more offerings, which may be through one or more underwriters, dealers andents, or directly to the purchasers. The names of any underwriters, dealers orents, if any, will] [Three Months Ended Year Ended March 31, 2013 2013 2012 2011 2010 2009 Ratio of earnings to fixed charges 2.5 3.2 27.6 30.6 19.2 30.1 Earnings: Three Months Ended Year Ended March 31, RMB000 2013 2013 2012 2011 2010 2009ome beforeome tax 44,432 158,185 151,599 132,142 79,663 42,299d: Fixed charges] [Consent of Independent Registered Public Accounting Firm The Board of Directors Chinard Bloodrporation Wensent to the use of our reportsted July 31, 2013, with respect to thensolidated balance sheets of Chinard Bloodrporation and subsidiaries of March 31, 2012 and 2013, and the relatednsolidated statements ofmprehensiveome, changes in equity, andsh flows for each of the years]
KZ [KONGZHONG] CORRESP: (Original Filing)
[October 30, 2013 Via Facsimile and EDGAR Mr. Larry Spirgel Re: KongZhong Corporation Annual Report on Form 20-F for the Fiscal Year ended December 31, 2012 filed on April 16, 2013 Dear Mr. Spirgel: For your convenience, the Company has included the Staff’s comments in this response letter in italicized form and keyed its responses accordingly. The Company’s responses to]
WUBA [58.com] EFFECT: (Original Filing)
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
QUNR [Qunar Cayman Islands] FWP: Issuer Free Writing Prospectus Registration No. 333-191459 October
[Issuer Free Writing Prospectus Registration No. 333-191459 October 30, 2013 Qunar Cayman Islands Limited Qunar Cayman Islands Limited, or our company, has filed a registration statement on Form F- 1, including a prospectus, with Commission, or the SEC, for the offering to which this free writing prospec tus relates. Before you invest, you should read the prospectus in that registration]
CO [Chinard Bloodrp] F-3/A: Subject tompletion,ted October 30, 2013 PROSPECTUS $100,000,000 CHINARD
[Subject tompletion,ted October 30, 2013 PROSPECTUS $100,000,000 CHINARD BLOODRPORATION Ordinary Shares The securitiesvered by this prospectus may be offered and sold from time to time in one or more offerings, which may be through one or more underwriters, dealers andents, or directly to the purchasers. The names of any underwriters, dealers orents, if any, will] [Three Months Ended Year Ended March 31, 2013 2013 2012 2011 2010 2009 Ratio of earnings to fixed charges 2.5 3.2 27.6 30.6 19.2 30.1 Earnings: Three Months Ended Year Ended March 31, RMB000 2013 2013 2012 2011 2010 2009ome beforeome tax 44,432 158,185 151,599 132,142 79,663 42,299d: Fixed charges] [Consent of Independent Registered Public Accounting Firm The Board of Directors Chinard Bloodrporation Wensent to the use of our reportsted July 31, 2013, with respect to thensolidated balance sheets of Chinard Bloodrporation and subsidiaries of March 31, 2012 and 2013, and the relatednsolidated statements ofmprehensiveome, changes in equity, andsh flows for each of the years]
KZ [KONGZHONG] CORRESP: October 30, 2013 Via Facsimile and EDGAR Mr.
[October 30, 2013 Via Facsimile and EDGAR Mr. Larry Spirgel Re: KongZhong Corporation Annual Report on Form 20-F for the Fiscal Year ended December 31, 2012 filed on April 16, 2013 Dear Mr. Spirgel: For your convenience, the Company has included the Staff’s comments in this response letter in italicized form and keyed its responses accordingly. The Company’s responses to]
